Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ).
Jubilant Pharmova Limited has announced the approval of 1,506 Stock Options/Restricted Stock Units (RSUs) for eligible employees under the Jubilant Pharmova Employees Stock Option Plan 2018. This move is part of the company’s strategy to incentivize and retain talent, potentially impacting its operational efficiency and market positioning positively.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its innovative solutions and services in the healthcare sector, aiming to enhance global health outcomes.
Average Trading Volume: 8,283
Technical Sentiment Signal: Buy
Current Market Cap: 178.3B INR
See more insights into JUBLPHARMA stock on TipRanks’ Stock Analysis page.